BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 17409111)

  • 1. High plasma cholesteryl ester transfer protein levels may favour reduced incidence of cardiovascular events in men with low triglycerides.
    Borggreve SE; Hillege HL; Dallinga-Thie GM; de Jong PE; Wolffenbuttel BH; Grobbee DE; van Tol A; Dullaart RP;
    Eur Heart J; 2007 Apr; 28(8):1012-8. PubMed ID: 17409111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma levels of cholesteryl ester transfer protein and the risk of future coronary artery disease in apparently healthy men and women: the prospective EPIC (European Prospective Investigation into Cancer and nutrition)-Norfolk population study.
    Boekholdt SM; Kuivenhoven JA; Wareham NJ; Peters RJ; Jukema JW; Luben R; Bingham SA; Day NE; Kastelein JJ; Khaw KT
    Circulation; 2004 Sep; 110(11):1418-23. PubMed ID: 15337694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association of HDL cholesterol concentration with the -629C>A CETP promoter polymorphism is not fully explained by its relationship with plasma cholesteryl ester transfer.
    Dullaart RP; Borggreve SE; Hillege HL; Dallinga-Thie GM
    Scand J Clin Lab Invest; 2008; 68(2):99-105. PubMed ID: 17852818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholesteryl ester transfer protein activity and cardiovascular events in patients with chronic kidney disease stage V.
    Seiler S; Schlitt A; Jiang XC; Ulrich C; Blankenberg S; Lackner KJ; Girndt M; Werdan K; Buerke M; Fliser D; Heine GH
    Nephrol Dial Transplant; 2008 Nov; 23(11):3599-604. PubMed ID: 18503096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High plasma cholesteryl ester transfer but not CETP mass predicts incident cardiovascular disease: a nested case-control study.
    Kappelle PJ; Perton F; Hillege HL; Dallinga-Thie GM; Dullaart RP
    Atherosclerosis; 2011 Jul; 217(1):249-52. PubMed ID: 21524747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma cholesteryl ester transfer protein concentrations predict cardiovascular events in patients with coronary artery disease treated with pravastatin.
    Marschang P; Sandhofer A; Ritsch A; Fiŝer I; Kvas E; Patsch JR
    J Intern Med; 2006 Aug; 260(2):151-9. PubMed ID: 16882279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholesteryl ester transfer protein in metabolic syndrome.
    Sandhofer A; Kaser S; Ritsch A; Laimer M; Engl J; Paulweber B; Patsch JR; Ebenbichler CF
    Obesity (Silver Spring); 2006 May; 14(5):812-8. PubMed ID: 16855190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common variation in cholesteryl ester transfer protein: relationship of first major adverse cardiovascular events with the apolipoprotein B/apolipoprotein A-I ratio and the total cholesterol/high-density lipoprotein cholesterol ratio.
    Kappelle PJ; Gansevoort RT; Hillege HJ; Wolffenbuttel BH; Dullaart RP;
    J Clin Lipidol; 2013; 7(1):56-64. PubMed ID: 23351584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The plasma leptin/adiponectin ratio predicts first cardiovascular event in men: a prospective nested case-control study.
    Kappelle PJ; Dullaart RP; van Beek AP; Hillege HL; Wolffenbuttel BH
    Eur J Intern Med; 2012 Dec; 23(8):755-9. PubMed ID: 22819464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variation in the cholesteryl ester transfer protein (CETP) gene does not influence individual plasma cholesterol response to changes in the nature of dietary fat.
    Aitken WA; Chisholm AW; Duncan AW; Harper MJ; Humphries SE; Mann JI; Murray Skeaff C; Sutherland WH; Wallace AJ; Williams SM
    Nutr Metab Cardiovasc Dis; 2006 Jul; 16(5):353-63. PubMed ID: 16829344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma triglycerides, an independent predictor of cardiovascular disease in men: a prospective study based on a population with prevalent metabolic syndrome.
    Onat A; Sari I; Yazici M; Can G; Hergenç G; Avci GS
    Int J Cardiol; 2006 Mar; 108(1):89-95. PubMed ID: 16085325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Higher frequency of abnormal serum angiopoietin-like protein 3 than abnormal cholesteryl ester transfer protein in Japanese hyperalphalipoproteinemic subjects.
    Moon HD; Nakajima K; Kamiyama K; Takanashi K; Sakurabayashi I; Nagamine T
    Clin Chim Acta; 2008 Dec; 398(1-2):99-104. PubMed ID: 18804459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A deficiency of cholesteryl ester transfer protein whose serum remnant-like particle-triglyceride significantly increased, but serum remnant-like particle-cholesterol did not after an oral fat load.
    Ai M; Tanaka A; Shimokado K; Ohtani R; Inazu A; Kobayashi J; Mabuchi H; Nakano T; Nakajima K
    Ann Clin Biochem; 2009 Nov; 46(Pt 6):457-63. PubMed ID: 19641010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated cholesteryl ester transfer protein concentration is associated with an increased risk for cardiovascular disease in women, but not in men, with Type 2 diabetes: the Hoorn Study.
    Alssema M; Dekker JM; Kuivenhoven JA; Nijpels G; Teerlink T; Scheffer PG; Diamant M; Stehouwer CD; Bouter LM; Heine RJ
    Diabet Med; 2007 Feb; 24(2):117-23. PubMed ID: 17257272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fasting cholesteryl ester transfer protein concentration is independently associated with the postprandial decrease in high-density lipoprotein cholesterol concentration after fat-rich meals: the Hoorn prandial study.
    Alssema M; El-Harchaoui K; Schindhelm RK; Diamant M; Nijpels G; Kostense PJ; Teerlink T; Heine RJ; Dallinga-Thie GM; Kuivenhoven JA; Dekker JM; Scheffer PG
    Metabolism; 2010 Jun; 59(6):854-60. PubMed ID: 20005542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of traditional and novel risk factors on the relationship between socioeconomic status and incident cardiovascular events.
    Albert MA; Glynn RJ; Buring J; Ridker PM
    Circulation; 2006 Dec; 114(24):2619-26. PubMed ID: 17116764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid-lowering therapy does not affect the postprandial drop in high density lipoprotein-cholesterol (HDL-c) plasma levels in obese men with metabolic syndrome: a randomized double blind crossover trial.
    Hajer GR; Dallinga-Thie GM; van Vark-van der Zee LC; Olijhoek JK; Visseren FL
    Clin Endocrinol (Oxf); 2008 Dec; 69(6):870-7. PubMed ID: 18394022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholesteryl ester transfer protein B1B1 genotype is associated with a parental history of cardiovascular diseases in Taiwanese people.
    Hsieh MC; Chen CC; Wang JY; Chong IW; Yhe CJ; Shin SJ; Lin SR
    Med Princ Pract; 2008; 17(2):143-8. PubMed ID: 18287799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum lipid profiles and their relationship to cardiovascular disease in the elderly: the PREV-ICTUS study.
    Lozano JV; Pallarés V; Cea-Calvo L; Llisterri JL; Fernández-Pérez C; Martí-Canales JC; Aznar J; Gil-Guillén V; Redón J;
    Curr Med Res Opin; 2008 Mar; 24(3):659-70. PubMed ID: 18218194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of cholesteryl ester transfer protein -629C > A polymorphism with high-density lipoprotein cholesterol levels in coronary artery disease patients.
    Tanrikulu S; Ademoglu E; Gurdol F; Mutlu-Turkoglu U; Bilge AK; Nisanci Y
    Cell Biochem Funct; 2009 Oct; 27(7):452-7. PubMed ID: 19784962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.